Core Scientific secured $600 million in credit facilities, pushing its stock to test technical resistance levels.
Core Scientific Inc. (CORZ) stock is trading at $18.03, up 3.5% on the day and approaching its intraday high. The share price has moved above key short-term moving averages but remains below medium- and long-term trend levels. Recent performance metrics show a 48-hour gain of 6.07%, a 7-day increase of 3.41%, a 1-month decline of 21.51%, a 3-month rise of 11.46%, a 6-month drop of 0.79%, and a 12-month surge of 47.05%. On August 27, the stock closed at $17.62, up 1.15%, with a daily trading range of $17.83 to $18.52 and a weekly range of $17.15 to $19.19.
Liquidity and financial flexibility have been significantly bolstered by two major corporate developments. According to Investingnews, Core Scientific has secured $600 million in committed senior secured credit facilities, comprising a $100 million revolving credit facility and a $500 million letter of credit facility. This substantial capital commitment immediately strengthens the company’s balance sheet and fosters increased investor demand for CORZ shares. Additionally, the recently completed $444 million all-cash acquisition of Polaris DS expands Core Scientific’s asset base and operational reach, positioning the company for further synergies and supporting the positive fundamentals driving the current price action.
From a technical perspective, the $18.03 price level sits above the 20-day moving average (MA-20) at $17.67 but remains below the 50-day moving average (MA-50) at $18.15 and well under the 200-day moving average (MA-200) at $19.69. The Ichimoku Kijun line at $17.67 serves as the nearest support level. Momentum indicators present a mixed outlook: the MACD is in sell territory, the Average Directional Index (ADX) remains neutral, the Relative Strength Index (RSI) stands at 40.08, and both the Stochastic RSI and Commodity Channel Index (CCI) display sell signals. Conversely, Bull/Bear Power is in buy mode, highlighting net intraday buying interest despite the generally bearish momentum readings.
Looking ahead over the next two to three trading days, the base case projects CORZ to consolidate within a volatile band of $17.12 to $18.94. Market models assign a 53% probability to an upside move and a 47% likelihood of a retracement. Price action is expected to remain confined within this range unless a significant breakout above resistance or a decisive breakdown below support occurs. While Core Scientific shares previously faced pressure from persistent technical weakness and disappointing earnings, recovery now hinges on overcoming the immediate $18.94 resistance level. The fresh capital commitments and strategic acquisition provide a positive fundamental backdrop that could catalyze any breakout-driven upside.
The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.